Keyphrases
Breast Cancer Patients
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Cardiotoxicity
100%
Doxorubicin
100%
Breast Cancer
25%
Cardiomyopathy
25%
Cardiac Biomarkers
25%
High Dose
12%
Inflammatory Biomarkers
12%
Chicago
12%
Newly Diagnosed
12%
Leukemia Patients
12%
Non-associated
12%
Large Cohort
12%
Prospective Cohort Study
12%
Multivariable
12%
University Medical Centre
12%
Doxorubicin Treatments
12%
6-month Follow-up
12%
High-sensitivity C-reactive Protein (hs-CRP)
12%
Clinical Endpoints
12%
Left Ventricular Ejection Fraction
12%
Troponin
12%
Cardiovascular Outcomes
12%
Percent Change
12%
1-year Follow-up
12%
Clinically Insignificant
12%
12-month Follow-up
12%
End of Treatment
12%
Left Ventricular Strain
12%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
12%
Prognostic Utility
12%
Very Low Risk
12%
Lymphoma Patients
12%
Serial Echocardiography
12%
Prognosticate
12%
Absolute Change
12%
January 2017
12%
Mixed Effects Linear Regression
12%
Global Longitudinal Strain
12%
Subclinical Cardiotoxicity
12%
Medicine and Dentistry
Breast Cancer
100%
Urokinase Receptor
100%
Doxorubicin
100%
Cardiotoxicity
100%
Biological Marker
37%
Myocardial Disease
25%
Cardiovascular System
12%
C Reactive Protein
12%
Drug Megadose
12%
Leukemia
12%
Hormone Precursor
12%
Linear Regression Analysis
12%
Echocardiography
12%
Amino Terminal Sequence
12%
Clinical Endpoint
12%
Heart Left Ventricle Ejection Fraction
12%
Prospective Cohort Study
12%
Troponin I
12%
Brain Natriuretic Peptide
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Urokinase Receptor
100%
Doxorubicin
100%
Cardiotoxicity
100%
Biological Marker
37%
Myocardial Disease
25%
Leukemia
12%
C Reactive Protein
12%
Hormone Precursor
12%
Prospective Cohort Study
12%
Troponin I
12%
Brain Natriuretic Peptide
12%
Biochemistry, Genetics and Molecular Biology
Urokinase Receptor
100%
Doxorubicin
100%
N-Terminus
12%
Drug Megadose
12%
C-Reactive Protein
12%
Prospective Cohort Study
12%
Heart Left Ventricle Ejection Fraction
12%
Troponin I
12%
Brain Natriuretic Peptide
12%